deflazacort has been researched along with Hangman Fracture in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, SF; Bushby, K; Guglieri, M; Horrocks, I; Joseph, S; Straub, V; Wang, C; Wong, SC | 1 |
| Reilly, CW; Schaeffer, EK; Singh, A | 1 |
| Belmatoug, N; Cacoub, P; Chemlal, K; Cohen, P; De Gennes, C; Khalifa, P; Piette, JC; Verdoncq, B; Wechsler, B; Ziza, JM | 1 |
| Gnudi, S; Malaguti, C; Merlini, L; Politano, L; Talim, B | 1 |
1 trial(s) available for deflazacort and Hangman Fracture
| Article | Year |
|---|---|
Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcium; Double-Blind Method; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Pregnenediones; Prospective Studies; Spinal Fractures; Treatment Outcome; Vitamin D | 2001 |
3 other study(ies) available for deflazacort and Hangman Fracture
| Article | Year |
|---|---|
Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar Database.
Topics: Adolescent; Back Pain; Body Height; Bone Density Conservation Agents; Case-Control Studies; Child; Cohort Studies; Diphosphonates; Fractures, Bone; Glucocorticoids; Growth Disorders; Humans; Incidence; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Osteoporotic Fractures; Pregnenediones; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spinal Fractures; United Kingdom | 2019 |
Vertebral Fractures in Duchenne Muscular Dystrophy Patients Managed With Deflazacort.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Osteoporotic Fractures; Pamidronate; Pregnenediones; Quality of Life; Retrospective Studies; Risk Factors; Spinal Fractures; Time Factors; Walking | 2018 |
Vertebral compression in Duchenne muscular dystrophy following deflazacort.
Topics: Adolescent; Humans; Immunosuppressive Agents; Lumbar Vertebrae; Male; Muscular Dystrophy, Duchenne; Pregnenediones; Spinal Fractures; Thoracic Vertebrae | 2002 |